Efficacy Testing of Crassocephalum Rabens Extract Capsules

Greenyn Biotechnology

Status: Completed

Conditions: Aging

Treatments: Dietary Supplement: Crassocephalum rabens extract

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT05309161

21-129-A

Details and patient eligibility

About

This study is to investigate the improveing effects of the Crassocephalum rebens extract on skin conditions in normal people.

Enrollment: 40 patients

Sex: All

Ages: 20+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. Age over 20 years
2. Healthy people

Exclusion criteria

1. Non-volunteer
2. Pregnant and lactating women
3. Hypersensitivity to the assigned product
4. Diagnosed with skin diseases, liver diseases, kinedy disease, and other severe diseases
5. Cosmetic, drug, or food allergies
6. Concurrent aesthetic treatments (e.g., intense pulse light, medical peelings, or laser therapy)
7. Aceepted aesthetic treatments one month ago before the study
8. Chronic sun exposure (over 3 hours/day)
9. The members of the research team

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

40 participants in 2 patient groups, including a placebo group

A group (placebo)

Placebo Comparator group

Description:

Placebo

Treatment:

Dietary Supplement: Crassocephalum rabens extract

B group (experimental)

Active Comparator group

Description:

Crassocephalum rabens extract

Treatment:

Dietary Supplement: Crassocephalum rabens extract